MedTrace Logo

Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

NCT05559853 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2026-03-06

No results posted yet for this study

Summary

The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor growth from worsening of cancer and growth from the effects of treatment in participants who have brain tumors treated with radiation therapy called stereotactic radiosurgery (SRS).

Conditions

  • Brain Metastases
  • Brain Metastases, Adult
  • Metastatic Brain Tumor
  • Metastatic Brain Cancer

Interventions

DIAGNOSTIC_TEST

CEST-MRF

CEST-MRF enables accurate quantification of both proton exchange rates and volume fractions in a fraction of the time required by conventional pulse sequences will be developed and optimized.

Sponsors & Collaborators

Principal Investigators

  • Ouri Cohen, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2027-09-22
Completion
2027-09-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05559853 on ClinicalTrials.gov